A newly published study in the journal Urology (the “Gold Journal”) has suggested that — at least for patients with a PSA level between 4 and 10 ng/ml — PSA density may be better than PSA level in the determination of which of these patients need to go on to have a biopsy. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, density, Diagnosis, PSA, risk | 7 Comments »
There have been a number of suggestions (as yet unproven) that African American men (and perhaps other men of black African ethnicity) may be less good candidates for active surveillance than men of Caucasian and Hispanic ethnicity. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, African American, density, ethnicity, Management, PSA, risk, surveillance | Leave a comment »
Regular readers will be aware that a PSA density (i.e., PSA ÷ prostate volume) > 0.15 has been identified and characterized as a risk factor for clinically significant prostate cancer by researchers at Johns Hopkins. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: density, Diagnosis, PCA3, risk | 4 Comments »
Being diagnosed with low-risk prostate cancer is a good reason to consider management under active surveillance (as opposed to immediate, early intervention) … but active surveillance won’t be right for every low-risk patient! … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active surveillance, density, extent, Management, PSA, risk | 11 Comments »
A recent study reported in the Journal of Clinical Endocrinology and Metabolism has been receiving a good deal of media attention, although its immediate clinical importance wouldn’t appear to be particularly high. … READ MORE …
Filed under: Uncategorized | Tagged: ADT, androgen deprivation therapy, bone, density, fragility | 2 Comments »
We learned a few other interesting tidbits during a variety of sessions and conversations today. … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Prevention, Risk, Treatment, Uncategorized | Tagged: abiraterone, bevacizumab, density, early, hormone therapy, late, risk, statin, urologist | Leave a comment »
There are several interesting news items today, as follows:
Filed under: Diagnosis, Management, Treatment, Uncategorized | Tagged: active, androgen, cancer, catheter, CTC, density, deprivation, ethnicity, news, prostate, PSA, race, surveillance, update | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 